We found that patients with HS had a significantly greater frequency of CD4+ IL-17+ cells, indicating that circulating Th17 cells in patients with HS have an increased intrinsic ability to produce IL-17 (Table S2; Fig. 2C). Here, CD4 is linked to histiocytic sarcoma.